Smart Blood Analytics Swiss SA
PrivateCompany Overview
Smart Blood Analytics Swiss SA is a healthcare technology company that develops AI-driven clinical decision support systems for the interpretation of blood test results.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Healthcare Analytics, Patient Engagement, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Smart Blood Analytics Swiss SA Comparables
Compare Smart Blood Analytics Swiss SA with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kantesti | 83% | |
| Dr. Max Health | 77% | |
| AI DiagMe | 76% | |
Smart Blood Analytics Swiss SA Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
Monthly visitors grew 92% MoM, from 2.8K to 5.5K.
- Jul 17, 2025
Grew 30% QoQ from 10 to 13 employees.
Smart Blood Analytics Swiss SA Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Smart Blood Analytics Swiss SA's valuation, stock price, and market status.